Business
CytoSorbents Appoints Terri Anne Powers, IRC as Vice President of Investor Relations and Corporate Communications
Terri Anne Powers, IRC, experienced financial and communications professional, to strengthen and expand relationships with the investment and broader
About this update from Cytosorbents Corporation
[{"type":"text","content":"Terri Anne Powers, IRC, experienced financial and communications professional, to strengthen and expand relationships with the investment and broader stakeholder community by building best-in-class investor relations and corporate communications function\n\n\nMONMOUTH JUNCTION, N.J., June 1, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care therapy leader commercializing its CytoSorb® blood purification technology to treat deadly conditions in critically ill and cardiac surgery patients around the world, announces the appointment of Terri Anne Powers, MBA, IRC, as Vice President of Investor Relations and Corporate Communications effective today. \n\n \n \n \n \n \n \n\n \nCytoSorbents hires Terri Anne Powers as VP of IR and Corporate Communications to build best-in-class investor relationsMs. Powers was most recently Vice President of Investor Relations at publicly-traded Diplomat Pharmacy, Inc., the largest independent provider of specialty pharmacy services in the United States, prior to its acquisition in 2020. At Diplomat, she established the in-house investor relations function and supported overall corporate communications. Prior to Diplomat, Ms. Powers spent nine years as Director of North American Investor Relations for France-based Veolia Environnement, a publicly-traded global water, waste, and energy services leader.\nPowers has more than 15 years of experience in the healthcare industry. In addition to her time at Diplomat, Powers spent seven years as an associate sell side analyst covering healthcare distribution and services equities at Robert W. Baird and Prudential Securities. Ms. Powers started her career as a chemist conducting research and development in the pharmaceutical industry at the G.D. Searle unit of Monsanto, where she also held other roles in preclinical drug development and as a global market research analyst.\nMs. Powers received her M.B.A. in finance and strategic management from the University of Chicago Booth School of Business. She received her B.S. in chemistry from Alma College, where she graduated with summa cum laude and Phi Beta Kappa honors. Ms. Powers is also an active member of NIRI, the National Investor Relations Institute, and holds the Investor Relations Charter (IRC) credential.\nMs. Powers stated, \"I am thrilled to join CytoSorbents at such an exciting...